Solvency II continues to dominate regulatory discussions in Europe, but Guenter Droese, chairman of ECIROA, is increasingly upbeat about the implications of its final form for the continent’s captive sector.
Economic ructions in Europe and delays to Solvency II are threatening to derail a grand European exercise. Carlos Montalvo, executive director of EIOPA defends current progress of the wide-ranging regime.
The captive sector faces challenging economic conditions globally and hardening attitudes in the US. Dennis Harwick, president of CICA, outlines the steps being taken to defend the sector's position.
With a second term finally won, Obama looks set to continue with his great healthcare project. The Patient Protection and Affordable Care Act will have implications for the captive sector, in Cayman and beyond.
Information technology is playing an increasingly prominent role in helping captives understand, manage and strengthen their claims and litigation process. Gary R Markham of LSG discusses the role IT is playing.
The PPACA has the potential to change the US healthcare landscape dramatically. The captive industry will be watching developments closely, with new medical institutions offering the potential for significant new entrants.
After months of uncertainty, it seems that Bermuda’s approach to Solvency II equivalency is likely to differentiate captives from the wider commercial market.
Bermuda’s captive sector looks finely poised to carve out a beneficial position within the Solvency II framework. Steve Chirico of AM Best discusses the regimes benefits and the Island’s unique in the regulatory landscape.
Bermuda continues to blaze an impressive trail across the captive landscape. Here, Mark Allitt and Jason Carne of KPMG outline the Island’s continuing efforts to position itself at the forefront of captive jurisdictions.
The Nonadmitted and Reinsurance Reform Act is proving a thorny issue for captives. Do they pursue a potential home state advantage conferred by the act or hope for a captive exclusion?